Abstract
Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third "90%" (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and €'supported, cost-effective, and tailored to a wide range of global communities.
Original language | English (US) |
---|---|
Pages (from-to) | 1487-1491 |
Number of pages | 5 |
Journal | Clinical Infectious Diseases |
Volume | 66 |
Issue number | 10 |
DOIs | |
State | Published - May 2 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© The Author(s) 2018.
Keywords
- 90-90-90
- antiretroviral therapy (ARV)
- human immunodeficiency virus (HIV)
- low- and middle-income countries (LMICs)
- viral suppression